Yasmin Hashambhoy-Ramsay, Jounce Therapeutics, “Using Modeling to Inform Critical Decisions: Three Stories of Preclinical Molecules”
Jump to:
Bio
“Using Modeling to Inform Critical Decisions: Three Stories of Preclinical Molecules”
Yasmin Hashambhoy-Ramsay is a computational biologist working in the biotech industry in Cambridge, Massachusetts. She was born and raised in Toronto and obtained her undergraduate degree in Applied Mathematics and Engineering at Queen’s University. A strong desire to help patients drew her to Johns Hopkins, and she is a proud alumna of the BME PhD program. She graduated from Dr. Rai Winslow’s lab and worked as a postdoctoral fellow with Dr. Feilim Mac Gabhann. As a Principal Scientist at Merrimack Pharmaceuticals, she used modeling to help advance drug development on various antibody and nanotherapeutic preclinical teams. She looks forward to starting a new position at Jounce Therapeutics in April as a Senior Bioinformatics Scientist.
Abstract
“Using Modeling to Inform Critical Decisions: Three Stories of Preclinical Molecules”
When I was a graduate student and postdoc at Hopkins, I loved doing biomedical research. The thought of taking rational, engineering approaches to understand biological mechanisms really appealed to me; however, I wasn’t sure if folks in industry appreciated these approaches too. It turns out that they do, and lots of pharmaceutical companies use computational biology to inform critical decisions. Over the past five years, I have worked on a number of preclinical teams at Merrimack Pharmaceuticals. In this talk, I will share three stories describing how I used different modeling approaches to answer critical questions that helped advance the development of early stage oncology drugs.
